Cargando…
Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide and affects approximately one third of adults in the United States. The disease is becoming a global epidemic as a result of the rising rates of obesity and metabolic disease. Emerging data suggest w...
Autores principales: | Hydes, Theresa J., Ravi, Sujan, Loomba, Rohit, E. Gray, Meagan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7641567/ https://www.ncbi.nlm.nih.gov/pubmed/32674529 http://dx.doi.org/10.3350/cmh.2020.0067 |
Ejemplares similares
-
Imaging biomarkers of NAFLD, NASH, and fibrosis
por: Ajmera, Veeral, et al.
Publicado: (2021) -
Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD
por: Bazick, Jessica, et al.
Publicado: (2015) -
Natural History of NAFLD/NASH
por: Ekstedt, Mattias, et al.
Publicado: (2017) -
The role of the microbiome in NAFLD and NASH
por: Kolodziejczyk, Aleksandra A, et al.
Publicado: (2018) -
Noninvasive Diagnosis of NAFLD and NASH
por: Piazzolla, Valeria Annarita, et al.
Publicado: (2020)